CV2 LIPID LEVELSAND NCEPATP-III LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS NEWLY-INITIATED ON ROSUVASTATIN ORATORVASTATIN
May 1, 2005, 00:00
10.1016/S1098-3015(10)62602-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)62602-2/fulltext
Title :
CV2 LIPID LEVELSAND NCEPATP-III LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS NEWLY-INITIATED ON ROSUVASTATIN ORATORVASTATIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62602-2&doi=10.1016/S1098-3015(10)62602-2
First page :
Section Title :
Open access? :
No
Section Order :
37